276. IDSA/ATS Guidelines for the Management of Adults with HAP/VAP: 2016 Update
Sunday, October 30, 2016: 8:00 AM-9:15 AM
Room: 383-385
Co-organized with the IDSA Clinical Affairs Committee and SHEA Guidelines Committee

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the process and evaluation performed for this new guideline update
  • examine the current approaches to managing adult patients with HAP/VAP
  • discuss the recommendations proposed by the updated IDSA/ATS Guidelines on the management of adults with HAP/VAP

Target Audience: Academicians, Clinicians, Fellows, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases physicians, Members-in-training, Pharmacists, Researchers, Scientists

Tracks: Adult ID

Moderators:  Andre C. Kalil, MD, MPH, FIDSA, University of Nebraska Medical Center and Mark Metersky, MD, University of Connecticut School of Medicine

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours .125 of pharmacy CE

ACPE Number: 0221-9999-16-303-L01-P


A. C. Kalil, None

M. Metersky, Bayer: Consultant and Grant Investigator , Consulting fee and Grant recipient

See more of: Mini-Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.